Home > PJ > News / Daily News

Return to PJ Online Home Page

The Pharmaceutical Journal Vol 267 No 7165 p337-341
15 September 2001

This article
Reprint
Photocopy


News summary


WHO warns on rising resistance

A warning that the benefit of $17bn spent developing new medicines in the past five years could be lost just as quickly has been issued by the World Health Organization.

The warning was made as the WHO launched a global strategy to contain the spread of resistance to medicines used to treat infectious diseases. The strategy recommends obligatory prescription requirements for antibiotics and the phasing out of antibiotics as growth promoters in animal husbandry. Nearly 50 per cent of all antibiotic production is currently used in agriculture.

“Rising resistance to antimicrobials is a problem faced by both rich and poor communities in industrialised, as well as developing, countries”, says Dr David Heymann, WHO executive director for communicable diseases. “It has different roots in different societies, but the net result and the imminent danger are the same.”

The WHO warning, issued on 11 September, says: “Without concerted global action many of the dramatic breakthroughs made in medical science over the past 50 years could be lost to the growing threat of drug resistance. Antibiotics were one of the most significant discoveries of the 20th century. Killer diseases such as tuberculosis, meningitis, scarlet fever and pneumonia could suddenly be treated and cured. Unless we act to protect these medical miracles, we could be heading for a post-antibiotic age in which many medical and surgical advances could be undermined by the risk of incurable infection.”

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal